Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stark DME hearing

This article was originally published in The Gray Sheet

Executive Summary

Rep. Pete Stark (D-Calif.), chairman of the House Ways and Means health subcommittee, plans April 14 hearing to address "issues relating to clinical laboratory services and durable medical equipment," according to a March 26 press release. The subcommittee points out that the Congressional Budget Office has estimated that President Clinton's fiscal year 1994 budget proposal ("The Gray Sheet" Feb. 22, p. 1) includes provisions that would reduce payments for DME by $651 mil. over five years. Stark recently introduced legislation (H.R. 1255) aimed at preventing DME-related fraud and abuse.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT000453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel